The Food and Drug Administration yesterday revoked its emergency use authorizations for all disposable respirators lacking National Institute of Occupational Safety and Health approval, and for decontamination and bioburden reduction systems used to extend the use of disposable respirators.

In a letter to health care providers, FDA said providers should no longer use these crisis capacity strategies based on the increased domestic supply of NIOSH-approved respirators. It said the change also was consistent with the Centers for Disease Control and Prevention’s updated recommendations for maximizing the supply of N95 respirators and the Emergency Temporary Standard recently published by the Occupational Safety and Health Administration.


In May, FDA recommended providers transition away from using disposable respirators not approved by NIOSH and decontamination or bioburden reduction to extend the use of disposable respirators due to increased supply of NIOSH-approved respirators.

Related News Articles

Headline
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee today by a unanimous vote recommended that the FDA issue an…
Headline
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19…
Headline
The Food and Drug Administration yesterday released an updated enforcement policy related to face masks, barrier face coverings, face shields,…
Headline
The Centers for Disease Control and Prevention Friday updated its guidance for health care personnel on preventing and controlling infections during the COVID-…
Headline
According to new Centers for Disease Control and Prevention research, hospitalization for COVID-19 for children and adolescents increased four-fold in August…
Headline
The Centers for Disease Control and Prevention yesterday alerted health care providers and the public to reports of severe illness associated with using…